Thomas M. Bridges

Also affiliated with Center for Discovery

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials”.

Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials

ACS Chemical Neuroscience(2024)10.1021/acschemneuro.4c00769

N/A

0.457DataRank · unranked

11 citations

Michael R. Wood, Changho Han, Shaun R. Stauffer, Joseph D. Panarese, Bruce J. Melancon +21 more

Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates

Neuropsychopharmacology(2020)10.1038/s41386-020-00812-7

N/A

0DataRank · unranked

20 citations

Jason K Russell, Michael T. Nedelcovych, Michael Bubser, Anna L. Blobaum, Thomas M. Bridges +6 more

Discovery of the first selective M 4 muscarinic acetylcholine receptor antagonists with in vivo anti-parkinsonian and anti-dystonic efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.12.324152

N/A

0DataRank · unranked

1 citations

Aaron M. Bender, Jonathan W. Dickerson, Daniel J. Foster, Yuping Donsante, Weimin Peng +14 more

Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study

British Journal of Ophthalmology(2021)10.1136/bjophthalmol-2020-318529

N/A

0DataRank · unranked

40 citations

Jessica V. Kaczmarek, Janene Pierce, Sheau‐Chiann Chen, Kelli L. Boyd, M. Wade Calcutt +11 more

Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.128416

N/A

0DataRank · unranked

8 citations

Rory A. Capstick, Paul K. Spearing, Julie L. Engers, Alison R. Gregro, Sean R. Bollinger +11 more

Discovery of VU6008677: A Structurally Distinct Tricyclic M4 Positive Allosteric Modulator with Improved CYP450 Profile

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00249

N/A

0DataRank · unranked

6 citations

Sean R. Bollinger, Julie L. Engers, Madeline F. Long, Sichen Chang, Vincent B. Luscombe +9 more